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Background: Surgical ligation of the left atrial appendage (LAA) has been shown to be an effective alternative to coumadin therapy in patients 
with atrial fibrillation (AF). A novel catheter-based approach for LAA ligation was evaluated for safety and effectiveness in a canine model and a first- 
in- man experience.
Methods: A total of 26 healthy mongrel dogs underwent ligation of the LAA via a catheter-based approach utilizing a magnet tipped guide wire 
system (FindrWIRZ™) comprised of a .025” endocardial guidewire placed in the apex of the LAA via transseptal catherization and a .035” epicardial 
guidewire placed via percutaneous pericardial approach, both having magnetic tips of opposite polarization. A 20 mm compliant occlusion balloon 
catheter was advanced over the endocardial guidewire and positioned at the orifice of the LAA under intracardiac echocardiography guidance. An 
over the wire approach was used to guide a catheter-based snare device (LARIAT II, SentreHeart, Inc) over the LAA to enable ligation of the LAA. 
Similar methods and transesophageal echocardiography were used in 3 humans undergoing radiofrequency catheter ablation for atrial fibrillation 
(AF).
Results: Dogs were euthanized acutely following the procedure (n=16), 7 days post-LAA ligation (n=3), 1 month post-LAA ligation (n=3) and 3 
months post-LAA ligation (n=4). The snare delivery device was able to completely capture, advance and close the anatomical base of the LAA in all 
cases. Complete left atrial appendage exclusion via this closed-chested approach was achieved in all animals without complications. Examination 
of the LAA at one month demonstrated completely endothelializion of orifice of the LAA. The human studies demonstrated immediate complete LAA 
closure confirmed by TEE and LA angiogram. No complications were noted.
Conclusion: A novel catheter-based snare achieved safe and reliable ligation of the entire LAA in a canine model and in man. The clinical 
application of this novel approach may provide an alternative to coumadin or to permanent device implants in non-valvular patients with AF for the 
prevention of embolic events originating from the LAA.
